...

ljamieson@heroza.org

Lise Jamieson, PhD

Research Associate

Research Associate

Lise Jamieson is a Senior Researcher at the Health Economics and Epidemiology Research Office (HE2RO), based in Johannesburg, South Africa. She holds a Masters degree in biostatistics and has worked in HIV and tuberculosis research since 2006. Her current interest areas include health economics modelling, with a focus on the long-term impact of HIV prevention and treatment interventions, and translating her research into recommendations for public health policy. Before joining HE2RO, she was based at CAPRISA, working on clinical trials and prospective cohort studies, on topics such as HIV prevention, HIV pathogeneses, antiretroviral therapy and TB treatment outcomes.

Recent publications

Youngji J, Jamieson L, Edoka I, Long L , S Sheetal Silal, Pulliam J.C.R, Moultrie H, Sanne I, Meyer-Rath G, Nichols BE (2021) Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa Open Forum Infectious Diseases doi: 10.1093/ofid/ofab040


Nichols, B.E., L. Jamieson, S.R.C Zhang, G.A. Rao, S. Silal, J.R.C. Pulliam, I. Sanne, and G. Meyer-Rath (2020) The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing intensive care unit capacity. Clinical Infectious Diseases 71(9): 1642–1644 doi: 10.1093/cid/ciaa937


DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis